GlycoMimetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GlycoMimetics and buy or sell other stocks, ETFs, and their options commission-free!About GLYC
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.
CEOJoshua T. Brumm
CEOJoshua T. Brumm
Employees26
Employees26
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
Founded
Employees26
Employees26
GLYC Key Statistics
Market cap181.16M
Market cap181.16M
Price-Earnings ratio-0.55
Price-Earnings ratio-0.55
Dividend yield—
Dividend yield—
Average volume103.08K
Average volume103.08K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$37.00
52 Week high$37.00
52 Week low$9.81
52 Week low$9.81
Stock Snapshot
With a market cap of 181.16M, GlycoMimetics(GLYC) trades at $13.04. The stock has a price-to-earnings ratio of -0.55.
On 2025-12-30, GlycoMimetics(GLYC) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 103.08K.
The stock's 52-week range extends from a low of $9.81 to a high of $37.00.
The stock's 52-week range extends from a low of $9.81 to a high of $37.00.
People also own
Based on the portfolios of people who own GLYC. This list is generated using Robinhood data, and it’s not a recommendation.